Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0046264
Title: Interleukin 23 Promotes Hepatocellular Carcinoma Metastasis via NF-Kappa B Induced Matrix Metalloproteinase 9 Expression
Authors: Li J.
Lau G.
Chen L. 
Yuan Y.-F.
Huang J.
Luk J.M. 
Xie D.
Guan X.-Y.
Keywords: gelatinase B
immunoglobulin enhancer binding protein
interleukin 17
interleukin 23
transcription factor RelA
adult
article
cell invasion
cell migration
controlled study
female
human
human cell
human tissue
immunoblotting
immunohistochemistry
liver cell carcinoma
major clinical study
male
metastasis
polymerase chain reaction
protein expression
protein function
quantitative analysis
RNA interference
signal transduction
Carcinoma, Hepatocellular
Cell Movement
Humans
Immunohistochemistry
Interleukin-17
Interleukin-23
Liver Neoplasms
Matrix Metalloproteinase 9
Neoplasm Metastasis
NF-kappa B
Polymerase Chain Reaction
Animalia
Issue Date: 2012
Publisher: Public Library of Science
Citation: Li J., Lau G., Chen L., Yuan Y.-F., Huang J., Luk J.M., Xie D., Guan X.-Y. (2012). Interleukin 23 Promotes Hepatocellular Carcinoma Metastasis via NF-Kappa B Induced Matrix Metalloproteinase 9 Expression. PLoS ONE 7 (9) : e46264. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0046264
Abstract: Background: Hepatocellular carcinoma (HCC) is one of the most popular cancers in the world with poor prognosis, which often develops from chronic liver inflammatory diseases. Interleukin 23 (IL-23) is an inflammatory cytokine which is reported to play an important role in tumor development in animal model. While the function of IL-23 in HCC development remains unknown, so we investigate the role of IL-23 in HCC progression in this study. Methodology and Principal Finding: Transcript level of IL-23, interleukin17A (IL-17A) and matrix metalloproteinases 9 (MMP9) in clinical HCC samples (n = 81) was determined by qPCR. Protein expression pattern of IL-23 in primary and metastatic HCC tissues pairs (n = 49 pairs) was determined by immunohistochemistry staining. Cell migration, invasion, RNA interfering and immune blotting were used to characterize the functional and signaling mechanisms in IL-23-treated HCC. Compared with paired non-tumor tissue, higher IL-23 expression was detected in HCC tumor tissues with metastasis. Immunohistochemistry staining confirmed the high expression of IL-23 in metastasis HCC. Immune blotting demonstrated that IL-23 was highly expressed in HCC cell lines with metastasis. Functional study found that IL-23 could promote HCC cell migration and invasion. Molecular analysis revealed that IL-23 could upregulate MMP9 expression via NF-?B/p65 signaling activation and IL-17A could improve IL-23 expression in tumor cells directly via activating NF-?B/p65 signaling pathway. Conclusions: IL-23 could promote HCC metastasis by the upregulation of MMP9 expression via activating NF-?B/p65 signaling pathway. At the same time, IL-17A could further promote IL-23 expression in HCC tumor cells. © 2012 Li et al.
Source Title: PLoS ONE
URI: https://scholarbank.nus.edu.sg/handle/10635/166208
ISSN: 19326203
DOI: 10.1371/journal.pone.0046264
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0046264.pdf2.49 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

57
checked on Jul 5, 2020

Page view(s)

30
checked on Jul 9, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.